Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Post-acute Sequelae of SARS-CoV-2 Infection: A Neglected Public Health Issue
Zhonglei Wang, Liyan Yang
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 24

Showing 24 citing articles:

Bioactive natural products in COVID-19 therapy
Zhonglei Wang, Ning Wang, Liyan Yang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 56
Oral GS-441524 derivatives: Next-generation inhibitors of SARS‐CoV‐2 RNA‐dependent RNA polymerase
Zhonglei Wang, Liyan Yang, Xian-qing Song
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
The Therapeutic Potential of Natural Dietary Flavonoids against SARS-CoV-2 Infection
Zhonglei Wang, Liyan Yang
Nutrients (2023) Vol. 15, Iss. 15, pp. 3443-3443
Open Access | Times Cited: 25
Post-COVID-19 conditions: a systematic review on advanced magnetic resonance neuroimaging findings
Sana Mohammadi, Sadegh Ghaderi
Neurological Sciences (2024) Vol. 45, Iss. 5, pp. 1815-1833
Closed Access | Times Cited: 10
Eco-sustainable chromatographic method for the determination of favipiravir and nitazoxanide for COVID-19: application to human plasma
Amal B. Ahmed, Maha M. Abdelrahman, Fadwa H. Edrees
BMC Chemistry (2025) Vol. 19, Iss. 1
Open Access
How do German General Practitioners Manage Long-/Post-COVID? A Qualitative Study in Primary Care
Beatrice E. Bachmeier, Salome Hölzle, M. M. Gasser, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 1016-1016
Open Access | Times Cited: 15
How Does Long-COVID Impact Prognosis and the Long-Term Sequelae?
Carolina Baroni, Jorge Potito, María Eugenia Perticone, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1173-1173
Open Access | Times Cited: 11
Traditional Tibetan medicine to fight against COVID-19: Basic theory and therapeutic drugs
Kun Zhang, Lijie Wang, Jiayan Peng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Neuroimmunological Effect of Vitamin D on Neuropsychiatric Long COVID Syndrome: A Review
Ting‐Bin Chen, Ching‐Mao Chang, Cheng‐Chia Yang, et al.
Nutrients (2023) Vol. 15, Iss. 17, pp. 3802-3802
Open Access | Times Cited: 10
Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (Mpro)
Yue Yang, Yidan Luo, Chenbo Zhang, et al.
ACS Omega (2024) Vol. 9, Iss. 32, pp. 34196-34219
Open Access | Times Cited: 3
Pituitary–Adrenal Axis and Peripheral Immune Cell Profile in Long COVID
Jaume Alijotas‐Reig, Ariadna Anunciación-Llunell, Enrique Esteve‐Valverde, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 581-581
Open Access | Times Cited: 2
Stand Up to Stand Out: Natural Dietary Polyphenols Curcumin, Resveratrol, and Gossypol as Potential Therapeutic Candidates against Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Zhonglei Wang, Xian-qing Song, Wenjing Xu, et al.
Nutrients (2023) Vol. 15, Iss. 18, pp. 3885-3885
Open Access | Times Cited: 7
Redox Biomarkers – An Effective Tool for Diagnosing COVID-19 Patients and Convalescents
Blanka Wolszczak-Biedrzycka, Justyna Dorf, Joanna Matowicka-Karna, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 2589-2607
Open Access | Times Cited: 2
Self-managing symptoms of Long COVID: an education and strategies research protocol
Julia Rybkina, Nithin Jacob, Brenda Colella, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
Inhibitory effect of phytochemicals towards SARS-CoV-2 papain like protease (PLpro) proteolytic and deubiquitinase activity
Anasha Kawall, Devin S. M. Lewis, Avini Sharma, et al.
Frontiers in Chemistry (2023) Vol. 10
Open Access | Times Cited: 3
Conventional Understanding of SARS‐CoV‐2 Mpro and Common Strategies for Developing Its Inhibitors
Kun Zhou, Daquan Chen
ChemBioChem (2023) Vol. 24, Iss. 22
Closed Access | Times Cited: 3
Clinical Investigation of Leukocyte DNA Damage in COVID-19 Patients
Hasan Doğan, Aslı Kara, Erdem Çankaya, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 2, pp. 963-974
Open Access | Times Cited: 2
Inflammatory predictors (eosinophil, C-RP and IL-6) and effectiveness of oral Azvudine tablets treatment in COVID-19 hospitalized patients: A retrospective, self-controlled study
Yanli Zhao, Gan Gao, Wenhui Li, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21941-e21941
Open Access | Times Cited: 2
Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
Efstathios S. Giotis, Emine Çil, Greg N. Brooke
Viruses (2022) Vol. 14, Iss. 12, pp. 2728-2728
Open Access | Times Cited: 4
Ebbing Strength, Fading Power: Unveiling the Impact of Persistent Fatigue on Muscle Performance in COVID-19 Survivors
Mateusz Kowal, Ewa Morgiel, Sławomir Winiarski, et al.
Sensors (2024) Vol. 24, Iss. 4, pp. 1250-1250
Open Access
Vaccine and antiviral drug promise for preventing post-acute sequelae of COVID-19, and their combination for its treatment
Tomonari Sumi, Kouji Harada
Frontiers in Immunology (2024) Vol. 15
Open Access
The value of age IgG and IL6 in estimating time of viral clearance in asymptomatic or mild patients with COVID-19
Xi Cao, Yongli Xie, Chunlei Zhou, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 1
Effectiveness and safety analysis of SanHanHuaShi granules for the treatment of coronavirus disease 2019: Study protocol and statistical analysis plan for a randomized, parallel-controlled, open-label clinical trial
Yangyang Liu, Xi Chen, Hongan Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 2
Clinical Characteristics of 254 COVID-19 Inpatients in Yichang, Hubei, China, and Efficacy of Integrated Chinese and Western Medicine Treatment
Yongxin Yi, Jiayang Fang, Yunzhu Liu, et al.
International Journal of General Medicine (2022) Vol. Volume 15, pp. 8191-8200
Open Access
Page 1

Scroll to top